.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Julphar
Merck
Argus Health
Citi
Dow
Chinese Patent Office
Deloitte
Harvard Business School

Generated: December 17, 2017

DrugPatentWatch Database Preview

VALTREX Drug Profile

« Back to Dashboard

When do Valtrex patents expire, and when can generic versions of Valtrex launch?

Valtrex is a drug marketed by Glaxosmithkline and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and six patent family members in forty-five countries.

The generic ingredient in VALTREX is valacyclovir hydrochloride. There are twenty-two drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineVALTREXvalacyclovir hydrochlorideTABLET;ORAL020487-002Jun 23, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
GlaxosmithklineVALTREXvalacyclovir hydrochlorideTABLET;ORAL020487-001Jun 23, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineVALTREXvalacyclovir hydrochlorideTABLET;ORAL020487-002Jun 23, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
GlaxosmithklineVALTREXvalacyclovir hydrochlorideTABLET;ORAL020487-001Jun 23, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: VALTREX

Country Document Number Estimated Expiration
African Intellectual Property Organization (OAPI)10499► Subscribe
Romania118175► Subscribe
Turkey9700657► Subscribe
Austria302777► Subscribe
JapanH11503718► Subscribe
Poland321361► Subscribe
African Regional IP Organization (ARIPO)9701058► Subscribe
African Regional IP Organization (ARIPO)662► Subscribe
Japan3350055► Subscribe
Israel116831► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Teva
Daiichi Sankyo
Boehringer Ingelheim
Chinese Patent Office
Moodys
Johnson and Johnson
Citi
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot